Intersolar Europe in Munich: HZB research meets solar industry
Intersolar Europe is the world’s leading exhibition for the solar industry and its partners and takes place annually at the Messe München exhibition center in Munich, Germany.
© Solar Promotion GmbH
At the major international photovoltaics exhibition from 31 May to 2 June 2017, Helmholtz-Zentrum Berlin (HZB) will be exhibiting solar energy research projects and presenting opportunities for industrial cooperation in the field of photovoltaics (PV).
Intersolar Europe is a world leading event where manufacturers, suppliers, distributors and service providers come to learn of new developments in the solar industry. A team from Helmholtz-Zentrum Berlin will be presenting its research in the field of renewable energies at this exhibition in Hall A2, Booth 574 – in particular, the new Helmholtz Innovation Lab HySPRINT and the long-established competence centre for photovoltaics PVcomB. These two institutes primarily address the scientific-technical issues of technology transfer and cooperate closely with industrial partners.
In the Helmholtz Innovation Lab HySPRINT, silicon-based materials are being combined with organometallic perovskite crystals to develop so-called hybrid tandem cells. Such cells can be used for solar generation of electricity or hydrogen.
The Competence Centre Thin-Film- and Nanotechnology for Photovoltaics Berlin (PVcomB) has industrial reference lines for manufacturing CIGS and silicon photovoltaics. Teams of HZB experts are collaborating with industry to develop novel thin-film technologies and products. Joint research projects with industrial partners have already culminated in many successful innovations.
Research into new material systems for photovoltaics is an important focal topic at HZB. The Centre is specialised in so-called energy materials that convert or store energy. This includes solar cells, material systems for generating hydrogen from sunlight, and magnetic material systems for developing energy-efficient information technologies. For studying interfaces and surfaces of thin films, HZB operates the photon source BESSY II and a series of CoreLabs with latest generation equipment.
HZB’s info stand is in Hall A2, Booth 574 (A2.574)
- Green hydrogen: MXenes shows talent as catalyst for oxygen evolutionThe MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
- SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beerThe first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
- Review on ocular particle therapy (OPT) by international expertsA team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.